Danny M. Cohn

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

Journal: The New England journal of medicine

Published: June 15, 2026

Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes.

Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes.

Journal: Clinical reviews in allergy & immunology

Published: April 17, 2026

Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures.

Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures.

Journal: Frontiers in immunology

Published: February 13, 2026

The Chronic Angioedema Registry: what the first 2 years since the implementation of the global registry have taught us.

The Chronic Angioedema Registry: what the first 2 years since the implementation of the global registry have taught us.

Journal: Frontiers in allergy

Published: January 29, 2026

Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1.

Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1.

Journal: Journal of asthma and allergy

Published: January 21, 2026

Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical Studies.

Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical Studies.

Journal: Drug design, development and therapy

Published: January 07, 2026

Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.

Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.

Journal: The World Allergy Organization journal

Published: December 22, 2025

A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.

A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee.

Journal: Frontiers in immunology

Published: December 22, 2025

Donidalorsen for hereditary angioedema: Long-term results from a 4-year, phase 2, open-label extension study.

Donidalorsen for hereditary angioedema: Long-term results from a 4-year, phase 2, open-label extension study.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: December 17, 2025

Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.

Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.

Journal: The journal of allergy and clinical immunology. Global

Published: December 01, 2025

Pathogenesis of Heparin-Induced Thrombocytopenia.

Pathogenesis of Heparin-Induced Thrombocytopenia.

Journal: The New England journal of medicine

Published: November 19, 2025

An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema Attacks.

An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema Attacks.

Journal: Clinical and translational allergy

Published: October 21, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026